Статья
Связь полиморфизма генов AGT, ACE, NOS3, TNF, MMP9, CYBA c субклиническими изменениями артериальной стенки
Цель Активация ренин-ангиотензин-альдостероновой системы, снижение выработки оксида азота, хроническое воспаление и окислительный стресс приводят к субклиническим изменениям артериальной стенки, которые создают благоприятную среду для развития сердечно-сосудистых заболеваний (ССЗ). Влияние аллельных вариантов генов, кодирующих белки-участники патофизиологических путей развития возраст-ассоциированных заболеваний с субклиническими изменениями артериальной стенки [повышенной скоростью пульсовой волны (СПВ), утолщением комплекса интима-медиа, эндотелиальной дисфункцией (ЭД), наличием атеросклеротических бляшек (АСБ)] изучено недостаточно. В исследовании был проведен анализ связи полиморфизма генов AGT, ACE, NOS3 TNF, MMP9, CYBA с наличием субклинических изменений артериальной стенки, в том числе в зависимости от факторов риска ССЗ у относительно здоровых людей разного возраста.Материал и методы Изучена связь полиморфизма с.521С>Т гена AGT, Ins>Del гена AСE, с.894G>T гена NOS3, – 238G>A гена TNF, – 1562С>T гена MMP9, c.214Т>С гена CYBA с параметрами изменения артериальной стенки и факторами риска ССЗ у 160 относительно здоровых человек путем построения моделей множественной логистической регрессии, а также анализа частот совместного появления двух признаков с помощью критерия согласия Пирсона (χ2) и точного теста Фишера.Результаты Выявлена связь DD-генотипа полиморфизма Ins>Del гена ACE с повышенной СПВ (p=0,006; отношение шансов (ОШ) =3,41, 95 % доверительный интервал (ДИ): 1,48–8,67) и ЭД (p=0,014; ОШ=2,60, 95 % ДИ: 1,22–5,68). Отмечалась связь генотипа GG полиморфизма с.894G>T гена NOS3 с ЭД (p=0,0087; ОШ=2,65, 95 % ДИ: 1,26–5,72), ТТ-генотипа полиморфизма с.894G>T гена NOS3 с АСБ (p=0,033; ОШ=0,034, 95 % ДИ: 0,001–0,549).Заключение Выявлена взаимосвязь полиморфных вариантов генов AСE, NOS3 с ЭД, повышенной артериальной жесткостью и наличием АСБ у пациентов с субклиническими изменениями артериальной стенки.
1. Nilsson P. Early vascular aging (EVA): consequences and prevention. Vascular Health and Risk Management. 2008;4(3):547–52. DOI: 10.2147/VHRM.S1094
2. Strazhesko ID, Tkacheva ON, Akasheva DU, Dudinskaya EN, Plokhova EV, Pykhtina VS et al. Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases. Frontiers in Genetics. 2017; 8:198. DOI: 10.3389/fgene.2017.00198
3. Gomez-Sanchez M, Gomez-Sanchez L, Patino-Alonso MC, Cunha PG, Recio-Rodriguez JI, Alonso-Dominguez R et al. Vascular aging and its relationship with lifestyles and other risk factors in the general Spanish population: Early Vascular Ageing Study. Journal of Hypertension. 2020;38(6):1110–22. DOI: 10.1097/HJH.0000000000002373
4. Yang W, Lu J, Yang L, Zhang J. Association of Matrix Metalloproteinase-9 Gene -1562C/T Polymorphism with Essential Hypertension: A Systematic Review and Meta-Analysis Article. Iranian Journal of Public Health. 2015;44(11):1445–52. PMID: 26744701
5. Abouelfath R, Habbal R, Laaraj A, Khay K, Harraka M, Nadifi S. ACE insertion/deletion polymorphism is positively associated with resistant hypertension in Morocco. Gene. 2018; 658:178–83. DOI: 10.1016/j.gene.2018.03.028
6. Luo J-Q, Wen J-G, Zhou H-H, Chen X-P, Zhang W. Endothelial Nitric Oxide Synthase Gene G894T Polymorphism and Myocardial Infarction: A Meta-Analysis of 34 Studies Involving 21068 Subjects. PLoS ONE. 2014;9(1): e87196. DOI: 10.1371/journal.pone.0087196
7. Cheng Y, An B, Jiang M, Xin Y, Xuan S. Association of Tumor Necrosis Factor-alpha Polymorphisms and Risk of Coronary Artery Disease in Patients with Non-alcoholic Fatty Liver Disease. Hepatitis Monthly. 2015;15(3): e26818. DOI: 10.5812/hepatmon.26818
8. Xu Q, Yuan F, Shen X, Wen H, Li W, Cheng B et al. Polymorphisms of C242T and A640G in CYBA Gene and the Risk of Coronary Artery Disease: A Meta-Analysis. PLoS ONE. 2014;9(1):e84251. DOI: 10.1371/journal.pone.0084251
9. Rai H, Parveen F, Kumar S, Kapoor A, Sinha N. Association of Endothelial Nitric Oxide Synthase Gene Polymorphisms with Coronary Artery Disease: An Updated Meta-Analysis and Systematic Review. PLoS ONE. 2014;9(11):e113363. DOI: 10.1371/journal.pone.0113363
10. Buraczynska K, Kurzepa J, Ksiazek A, Buraczynska M, Rejdak K. Matrix Metalloproteinase-9 (MMP-9) Gene Polymorphism in Stroke Patients. NeuroMolecular Medicine. 2015;17(4):385–90. DOI: 10.1007/s12017-015-8367-5
11. Isordia-Salas I, Santiago-Germán D, Cerda-Mancillas MC, Hernández-Juárez J, Bernabe-García M, Leaños-Miranda A et al. Gene polymorphisms of angiotensin-converting enzyme and angiotensinogen and risk of idiopathic ischemic stroke. Gene. 2019;688: 163–70. DOI: 10.1016/j.gene.2018.11.080
12. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Research. 2002;30(10):e47. DOI: 10.1093/nar/30.10.e47
13. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of Cardiovascular Events and All-Cause Mortality with Arterial Stiffness: a systematic review and meta-analysis. Journal of the American College of Cardiology. 2010;55(13):1318–27. DOI: 10.1016/j.jacc.2009.10.061
14. Zhong Q, Hu M-J, Cui Y-J, Liang L, Zhou M-M, Yang Y-W et al. Carotid–Femoral Pulse Wave Velocity in the Prediction of Cardiovascular Events and Mortality: An Updated Systematic Review and Meta-Analysis. Angiology. 2018;69(7):617–29. DOI: 10.1177/0003319717742544
15. Patel S, Rauf A, Khan H, Abu-Izneid T. Renin-angiotensin- aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies. Biomedicine & Pharmacotherapy. 2017; 94:317–25. DOI: 10.1016/j.biopha.2017.07.091
16. Rigat B, Hubert C, Corvol P, Soubrier R. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Research. 1992;20(6):1433. DOI: 10.1093/nar/20.6.1433-a
17. Marcus Y, Shefer G, Stern N. Adipose tissue renin– angiotensin–aldosterone system (RAAS) and progression of insulin resistance. Molecular and Cellular Endocrinology. 2013;378(1–2):1–14. DOI: 10.1016/j.mce.2012.06.021
18. Manrique C, Lastra G, Gardner M, Sowers JR. The Renin Angiotensin Aldosterone System in Hypertension: Roles of Insulin Resistance and Oxidative Stress. Medical Clinics of North America. 2009;93(3):569–82. DOI: 10.1016/j.mcna.2009.02.014
19. Aroor AR, DeMarco VG, Jia G, Sun Z, Nistala R, Meininger GA et al. The Role of Tissue Renin-Angiotensin-Aldosterone System in the Development of Endothelial Dysfunction and Arterial Stiffness. Frontiers in Endocrinology. 2013;4:161. DOI: 10.3389/fendo.2013.00161
20. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness. Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25(5):932–43. DOI: 10.1161/01.ATV.0000160548.78317.29
21. Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF et al. T Regulatory Lymphocytes Prevent Angiotensin II–Induced Hypertension and Vascular Injury. Hypertension. 2011;57(3):469– 76. DOI: 10.1161/HYPERTENSIONAHA.110.162941
22. Стражеско И.Д., Акашева Д.У., Дудинская Е.Н., Ткачева О.Н. Старение сосудов: основные признаки и механизмы. Кардиоваскулярная терапия и профилактика. 2012;11(4):93-100. DOI: 10.15829/1728-8800-2012-4-93-100
23. Cheng H-M, Park S, Huang Q, Hoshide S, Wang J-G, Kario K et al. Vascular aging and hypertension: Implications for the clinical application of central blood pressure. International Journal of Cardiology. 2017; 230:209–13. DOI: 10.1016/j.ijcard.2016.12.170
24. Nilsson PM. Early Vascular Aging in Hypertension. Frontiers in Cardiovascular Medicine. 2020; 7:6. DOI: 10.3389/fcvm.2020.00006
25. Logan JG, Engler MB, Kim H. Genetic Determinants of Arterial Stiffness. Journal of Cardiovascular Translational Research. 2015;8(1):23–43. DOI: 10.1007/s12265-014-9597-x
26. Yuan H, Wang X, Xia Q, Ge P, Wang X, Cao X. Angiotensin converting enzyme (I/D) gene polymorphism contributes to ischemic stroke risk in Caucasian individuals: a meta-analysis based on 22 case-control studies. International Journal of Neuroscience. 2015;126(6):488–98. DOI: 10.3109/00207454.2015.1036421
27. Bhatti GK, Bhatti JS, Vijayvergiya R, Singh B. Implications of ACE (I/D) Gene Variants to the Genetic Susceptibility of Coronary Artery Disease in Asian Indians. Indian Journal of Clinical Biochemistry. 2017;32(2):163–70. DOI: 10.1007/s12291-016-0588-3
28. Hussain M, Awan FR, Gujjar A, Hafeez S, Islam M. A case control association study of ACE gene polymorphism (I/D) with hypertension in Punjabi population from Faisalabad, Pakistan. Clinical and Experimental Hypertension. 2018;40(2):186–91. DOI: 10.1080/10641963.2017.1356842
29. Malueka RG, Dwianingsih EK, Sutarni S, Bawono RG, Bayuangga HF, Gofir A et al. The D allele of the angiotensin- converting enzyme (ACE) insertion/deletion (I/D) polymorphism is associated with worse functional outcome of ischaemic stroke. International Journal of Neuroscience. 2018;128(8):697–704. DOI: 10.1080/00207454.2017.1412962
30. Krishnan R, Sekar D, karunanithy S, Subramanium S. Association of angiotensin converting enzyme gene insertion/deletion polymorphism with essential hypertension in south Indian population. Genes & Diseases. 2016;3(2):159–63. DOI: 10.1016/j.gendis.2016.03.001
31. Стражеско И.Д., Ткачева О.Н. Клеточные механизмы морфологических и функциональных изменений артериальной стенки с возрастом и роль терапии статинами в их профилактике. Кардиология. 2015;55(7):89-96
32. Tousoulis D, Kampoli A-M, Tentolouris Nikolaos Papageorgiou C, Stefanadis C. The Role of Nitric Oxide on Endothelial Function. Current Vascular Pharmacology. 2012;10(1):4–18. DOI: 10.2174/157016112798829760
33. Zhao Y, Vanhoutte PM, Leung SWS. Vascular nitric oxide: Beyond eNOS. Journal of Pharmacological Sciences. 2015;129(2):83–94. DOI: 10.1016/j.jphs.2015.09.002
34. Meza CA, La Favor JD, Kim D-H, Hickner RC. Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS? International Journal of Molecular Sciences. 2019;20(15):3775. DOI: 10.3390/ijms20153775
35. El Dayem SM, Battah AA, El Bohy AEM, Ahmed S, Hamed M, El Fattah SNA. Nitric Oxide Gene Polymorphism is a Risk Factor for Diabetic Nephropathy and Atherosclerosis in Type 1 Diabetic Patients. Macedonian Journal of Medical Sciences. 2019;7(19):3132–8. DOI: 10.3889/oamjms.2019.831
36. Corapcioglu D, Sahin M, Emral R, Celebi ZK, Sener O, Gedik VT. Association of the G894T Polymorphism of the Endothelial Nitric Oxide Synthase Gene with Diabetic Foot Syndrome Foot Ulcer, Diabetic Complications, and Comorbid Vascular Diseases: A Turkish Case–Control Study. Genetic Testing and Molecular Biomarkers. 2010;14(4):483–8. DOI: 10.1089/gtmb.2010.0023
37. Johns R, Chen Z-F, Young L, Delacruz F, Chang N-T, Yu C et al. Meta-Analysis of NOS3 G894T Polymorphisms with Air Pollution on the Risk of Ischemic Heart Disease Worldwide. Toxics. 2018;6(3):44. DOI: 10.3390/toxics6030044
38. ALrefai AA, Habib MSE, Yaseen RI, Gabr MK, Habeeb RM. Association of endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications. Molecular and Cellular Biochemistry. 2016;421(1–2):103–10. DOI: 10.1007/s11010-016-2790-2
39. Campedelli FL, e Silva KSF, Rodrigues DA, Martins JVM, Costa IR, Lagares MH et al. Polymorphism of the gene eNOS G894T (Glu298Asp) in symptomatic patients with aterosclerosis. Genetics and Molecular Research. 2017;16(2). DOI: 10.4238/gmr16029550
40. Srivastava P, Badhwar S, Chandran DS, Jaryal AK, Jyotsna VP, Deepak KK. Imbalance between Angiotensin II - Angiotensin (1-7) system is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(3):2061–8. DOI: 10.1016/j.dsx.2019.04.042
41. Konukoglu D, Uzun H. Endothelial Dysfunction and Hypertension. Advances in Experimental Medicine and Biology. 2017; 956:511–40. DOI: 10.1007/5584_2016_90
42. Gimbrone MA, García-Cardeña G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circulation Research. 2016;118(4):620–36. DOI: 10.1161/CIRCRESAHA.115.306301
43. Johnson CT, Brewster LP. Carotid Artery Intima-Media Thickness and the Renin-Angiotensin System. Hospital Practice. 2013;41(2):54–61. DOI: 10.3810/hp.2013.04.1026
44. Wu S-S, Kor C-T, Chen T-Y, Liu K-H, Shih K-L, Su W-W et al. Relationships between Serum Uric Acid, Malondialdehyde Levels, and Carotid Intima-Media Thickness in the Patients with Metabolic Syndrome. Oxidative Medicine and Cellular Longevity. 2019; 2019:6859757. DOI: 10.1155/2019/6859757
45. Seyedsadjadi N, Berg J, Bilgin AA, Grant R. A Pilot Study Providing Evidence for a Relationship between a Composite Lifestyle Score and Risk of Higher Carotid Intima-Media Thickness: Is There a Link to Oxidative Stress? Oxidative Medicine and Cellular Longevity. 2018; 2018:4504079. DOI: 10.1155/2018/4504079
46. Дудинская Е.Н., Ткачева О.Н., Шестакова М.В., Браилова Н.В., Стражеско И.Д., Акашева Д.У. и др. Длина теломер и состояние сосудистой стенки у пациентов с сахарным диабетом 2 типа. Сахарный диабет. 2014;17(3):31-8. DOI: 10.14341/DM2014331-38
47. Zhou Y-Y, Qiu H-M, Yang Y, Han Y-Y. Analysis of risk factors for carotid intima-media thickness in patients with type 2 diabetes mellitus in Western China assessed by logistic regression combined with a decision tree model. Diabetology & Metabolic Syndrome. 2020;12(1):8. DOI: 10.1186/s13098-020-0517-8
48. Watanabe K, Ouchi M, Ohara M, Kameda W, Susa S, Oizumi T et al. Change of carotid intima-media thickness is associated with age in elderly Japanese patients without a history of cardiovascular disease. Geriatrics & Gerontology International. 2015;15(8):1023–30. DOI: 10.1111/ggi.12402
49. Paternoster L, Martinez-Gonzalez NA, Charleton R, Chung M, Lewis S, Sudlow CLM. Genetic Effects on Carotid Intima- Media Thickness: Systematic Assessment and Meta-Analyses of Candidate Gene Polymorphisms Studied in More Than 5000 Subjects. Circulation: Cardiovascular Genetics. 2010;3(1):15–21. DOI: 10.1161/CIRCGENETICS.108.834366
50. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of Clinical Cardiovascular Events with Carotid Intima- Media Thickness: A Systematic Review and Meta-Analysis. Circulation. 2007;115(4):459–67. DOI: 10.1161/CIRCULATIONAHA.106.628875
51. Wang W-Z. Association between T174M polymorphism in the angiotensinogen gene and risk of coronary artery disease: a meta-analysis. Journal of geriatric cardiology: JGC. 2013;10(1):59–65. DOI: 10.3969/j.issn.1671-5411.2013.01.010
52. Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: A meta-analysis. Atherosclerosis. 2012;220(1):128–33. DOI: 10.1016/j.atherosclerosis.2011.06.044
53. Fernández-Friera L, Fuster V, López-Melgar B, Oliva B, SánchezGonzález J, Macías A et al. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI. Journal of the American College of Cardiology. 2019;73(12):1371–82. DOI: 10.1016/j.jacc.2018.12.075
54. Husain K. Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World Journal of Biological Chemistry. 2015;6(3):209–17. DOI: 10.4331/wjbc.v6.i3.209